Medtronic Pays $85M Settlement in Infuse Lawsuit

Medtronic has agreed to pay $85 million to resolve a class action claim filed in December 2008 by its shareholders.

Advertisement

The suit was filed by the Minneapolis Firefighters Relief Association, alleging misrepresentation and omissions by the company. Under the settlement, Medtronic denies any misrepresentations or omissions.

The Firefighters Relief Association alleged that the company artificially inflated its stock price during an off-label promotion for its bone morphogenic protein product Infuse, according to a Mass Device report.

More Articles on Orthopedic Devices:

Ascendx Spine Signs Distribution Agreement With Swiss Company

5 Spine-Focused Device Company 2011 Financial Reports

Benvenue Medical Enrolls 250 Patients in Kyphoplasty Trial

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.